Mostly Markets
Subscribe
Stocks/Health Care/Health Care Distributors

McKessonMCK

Health Care Distributors · Irving, Texas · In the S&P 500
$994.58+1.40%After hours: $994.58 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 23.1% over 1 year
McKesson over 1 yearDaily close, $, to 30 Oct 2026
$800$900Nov2026MarMayJulSep$994.58$800NovMarJul$994.58
Source: Nasdaq daily closes
Market value$116B
Price to earnings26.6x
Forward P/E21.4x
Dividend yield0.38%
Year to date+21.2%
One year+23.1%
Next earningsWed 4 Nov, after the close
SectorHealth Care
52-week range (closes)
$725.17$1,030.12

Quality and valuation

How McKesson compares with other health care stocks. A description, not a recommendation.

McKesson and 5 health care distributors peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: in line with its sector

A weaker business than most health care companies, priced about in line with them.

McKesson trades at 21.4 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +8.8% vs +7.8%
  • Keeps less of each sale (gross margin): 3.6% vs 65.3%
  • Less profitable (operating margin): 1.6% vs 13.3%
  • Turns less of its sales into cash: 1.6% vs 15.9%
MCK trades at 21.4x forward earnings, above the sector medianForward p/e, Health Care Distributors peers
NVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xMCK21.4xJNJ25.1xLLY36.3xSector median 19.1xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xMCK21.4xJNJ25.1xLLY36.3xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 26.6x earnings, MCK is pricier than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
20x25x30xAverage 26.4x2025202626.6x20x30xAverage 26.4x2025202626.6x
Source: Nasdaq prices; SEC filings

Financials

From McKesson's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 7.7% from a year earlierQuarterly revenue, $bn, latest Q1 ’27
$0bn$50bn$100bnQ2 ’25Q4 ’25Q2 ’26$105bnQ1 ’27$0bn$50bn$100bnQ2 ’25Q4 ’25Q2 ’26$105bnQ1 ’27
Source: SEC filings
Growth sped up to +7.7% last quarterRevenue growth, year on year, %
0%10%20%Q2 ’25Q4 ’25Q2 ’267.7%Q1 ’270%10%20%Q2 ’25Q4 ’25Q2 ’267.7%Q1 ’27
Source: SEC filings
Operating margin was 1.3% last quarterOperating income as a share of revenue, %
0%1%2%Q2 ’25Q4 ’25Q2 ’261.3%Q1 ’270%1%2%Q2 ’25Q4 ’25Q2 ’261.3%Q1 ’27
Source: SEC filings
Free cash flow was $6.4 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$0bn$5bnQ2 ’25Q4 ’25Q2 ’26−$0.3bnQ1 ’27$0bn$5bnQ2 ’25Q4 ’25Q2 ’26−$0.3bnQ1 ’27
Source: SEC filings
Last 12 monthsMCKSector median
Revenue growth+8.8%+7.8%
Gross margin3.6%65.3%
Operating margin1.6%13.3%
Free cash flow margin1.6%15.9%
Price to earnings26.6x30.2x

Stories on McKesson

We haven't written about McKesson yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Distributors, by market value.

CompanyPriceTodayYTDValue
LLYEli Lilly$1,417.54+3.19%+31.9%$1.33T
JNJJohnson & Johnson$273.20−0.73%+32.0%$658B
ABBVAbbVie$294.89+1.41%+29.1%$521B
MRKMerck$149.52+2.18%+42.0%$369B
UNHUnitedHealth$406.97−0.96%+23.3%$365B
NVSNovartis$160.79−0.19%+16.6%$327B
AZNAstraZeneca$186.65+7.02%+6.4%$290B
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B